Cigna Corporation (CI)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cigna Corporation (CI) trades at $287.77 with AI Score 79/100 (Grade A). Cigna Corporation operates as a global health service company, providing insurance and related products and services. Market cap: $76.12B, Sector: Healthcare.
Price live · AI analysis from May 10, 2026CI stock analysis for 2026: Analysts have set a consensus price target of $332.62 for Cigna Corporation, suggesting 15.6% upside from the current price of $287.77. The AI MoonshotScore is 79/100, indicating a strong bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.
CI: 1/1 perspectives are bullish.
How is this calculated? →Cigna Corporation (CI) Healthcare & Pipeline Overview
Cigna Corporation, a major player in the healthcare sector, delivers insurance and health services through its Evernorth and Cigna Healthcare segments. With a focus on coordinated care and global reach, Cigna serves diverse clients, including employers, health plans, and government organizations, maintaining a significant market presence.
What Is the Investment Thesis for CI?
Cigna Corporation presents a compelling investment case based on its diversified healthcare service offerings and strategic market positioning. With a P/E ratio of 11.5 and a dividend yield of 2.11%, the company offers a blend of value and income. The Evernorth segment's integrated pharmacy and care solutions drive consistent revenue, while Cigna Healthcare benefits from the growing demand for Medicare and individual health plans. Key catalysts include ongoing expansion in international markets and continued innovation in healthcare technology. However, potential risks include regulatory changes in the healthcare industry and increasing competition from other major health insurers. The company's beta of 0.27 suggests lower volatility compared to the broader market.
Based on FMP financials and quantitative analysis
CI Key Highlights
- Market Cap of $76.12B reflects Cigna's significant presence in the healthcare industry.
- P/E Ratio of 11.5 indicates a potentially undervalued stock compared to its earnings.
- Dividend Yield of 2.11% provides a steady income stream for investors.
- Gross Margin of 9.3% demonstrates the profitability of Cigna's services.
- Beta of 0.27 suggests lower volatility compared to the broader market, making it a relatively stable investment.
Who Are CI's Competitors?
CI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CVS CVS Health Corporation | $104.72 | -0.09% | $133.62B | 74 |
| ELV Elevance Health Inc. | $417.89 | +0.41% | $90.75B | 86 |
| REGN Regeneron Pharmaceuticals, Inc. | $654.27 | +4.73% | $67.40B | 90 |
| COR Cencora, Inc. | $296.51 | +2.80% | $57.69B | 74 |
| BDX Becton, Dickinson and Company | $158.08 | +3.39% | $57.27B | 72 |
| ALHC Alignment Healthcare, Inc. | $23.80 | -0.87% | $4.92B | 52 |
| GTS Triple-S Management Corporation | $35.99 | +1.04% | 52 | |
| HUM Humana Inc. | $396.75 | -3.09% | $47.63B | 50 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CI's Key Strengths?
- Diversified service offerings through Evernorth and Cigna Healthcare.
- Strong brand recognition and market presence.
- Extensive network of healthcare providers.
- Focus on data analytics and technology innovation.
What Are CI's Weaknesses?
- High debt levels compared to some competitors.
- Exposure to regulatory changes in the healthcare industry.
- Dependence on government programs like Medicare and Medicaid.
- Profit Margin of 2.3% is relatively low compared to some peers.
What Could Drive CI Stock Higher?
- Expansion of Evernorth's pharmacy and care solutions.
- Growth in Medicare Advantage enrollment.
- Potential acquisitions to expand service offerings.
- Continued investment in digital health technologies.
- Strategic partnerships to enhance value-based care models.
What Are the Key Risks for CI?
- Insider selling — insiders were net sellers of roughly $59.4M recently.
- Regulatory changes impacting healthcare pricing and coverage.
- Increasing competition from other health insurers.
- Rising healthcare costs affecting profitability.
- Cybersecurity threats and data breaches.
- Economic downturn impacting enrollment and premium revenue.
What Are the Growth Opportunities for CI?
- Expansion of Evernorth Services: Cigna's Evernorth segment has significant growth potential through expanding its pharmacy benefits management, care delivery, and intelligence solutions. The market for pharmacy benefit management is projected to reach $600 billion by 2028, offering substantial opportunities for Cigna to increase its market share through innovative and cost-effective solutions. Timeline: Ongoing.
- Medicare Advantage Growth: The Medicare Advantage market is experiencing rapid growth, driven by increasing enrollment and favorable government policies. Cigna can capitalize on this trend by expanding its Medicare Advantage offerings and attracting more seniors seeking comprehensive healthcare coverage. The Medicare Advantage market is expected to reach $427 billion in 2026. Timeline: Ongoing.
- International Market Expansion: Cigna has the opportunity to expand its presence in international markets, particularly in regions with growing economies and increasing demand for healthcare services. By offering tailored health insurance solutions and leveraging its global network, Cigna can tap into new revenue streams and diversify its business. Timeline: Ongoing.
- Digital Health Innovation: Investing in digital health technologies, such as telehealth platforms and mobile health apps, can enhance Cigna's service offerings and improve customer engagement. The digital health market is projected to reach $660 billion by 2028, providing opportunities for Cigna to develop innovative solutions that improve healthcare access and outcomes. Timeline: Ongoing.
- Value-Based Care Models: Cigna can further integrate value-based care models into its operations, focusing on improving healthcare quality and reducing costs. By partnering with healthcare providers and implementing innovative payment models, Cigna can enhance its competitive position and drive better health outcomes for its members. Timeline: Ongoing.
What Opportunities Does CI Have?
- Expansion in international markets.
- Growth in the Medicare Advantage market.
- Adoption of digital health technologies.
- Integration of value-based care models.
What Threats Does CI Face?
- Increasing competition from other health insurers.
- Rising healthcare costs.
- Potential changes in government healthcare policies.
- Cybersecurity threats and data breaches.
What Are CI's Competitive Advantages?
- Scale: Cigna's large size and extensive network provide economies of scale and bargaining power.
- Brand Recognition: Cigna is a well-established and recognized brand in the healthcare industry.
- Integrated Services: The combination of Cigna Healthcare and Evernorth provides a comprehensive suite of services.
- Data Analytics: Cigna leverages data analytics to improve healthcare outcomes and reduce costs.
What Does CI Do?
Founded in 1792 and headquartered in Bloomfield, Connecticut, Cigna Corporation has evolved into a leading global health service company. Originally established as Insurance Company of North America (INA), the company merged with Connecticut General Life Insurance Company (CG) in 1982 to form Cigna. Today, Cigna operates through two primary segments: Evernorth and Cigna Healthcare. Evernorth provides coordinated and point solution health services, including pharmacy benefits management, care delivery and management, and intelligence solutions. Cigna Healthcare offers medical, pharmacy, behavioral health, dental, vision, and health advocacy programs to insured and self-insured customers. The company also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans, as well as individual health insurance plans. Cigna extends its services internationally, offering healthcare coverage to mobile individuals and employees of multinational organizations. Its distribution network includes insurance brokers, consultants, direct sales to employers and individuals, and private and public exchanges. Cigna's commitment to innovation and customer-centric solutions has solidified its position in the competitive healthcare landscape.
What Products and Services Does CI Offer?
- Provides medical, pharmacy, and behavioral health services.
- Offers dental and vision insurance plans.
- Administers health advocacy programs.
- Provides Medicare Advantage and Medicare Part D plans.
- Offers individual health insurance plans.
- Provides healthcare coverage in international markets.
- Offers pharmacy benefit management services through Evernorth.
- Provides care delivery and management solutions.
How Does CI Make Money?
- Generates revenue through premiums from health insurance plans.
- Earns fees from pharmacy benefit management services.
- Receives payments for care delivery and management services.
- Profits from providing health solutions to employers and government organizations.
What Industry Does CI Operate In?
Cigna operates in the dynamic and highly competitive healthcare industry. The market is characterized by increasing demand for comprehensive health services, driven by an aging population and rising healthcare costs. Key trends include the growth of value-based care, the adoption of digital health technologies, and the expansion of Medicare Advantage plans. Cigna competes with other major health insurers like CVS Health Corporation (CVS) and Elevance Health Inc. (ELV), as well as pharmacy benefit managers and specialized healthcare providers. The industry is subject to significant regulatory oversight, impacting pricing, coverage, and operational practices.
Who Are CI's Key Customers?
- Employers offering health benefits to their employees.
- Individuals seeking health insurance coverage.
- Seniors enrolled in Medicare Advantage and Medicare Part D plans.
- Multinational organizations providing health benefits to their employees.
- Government organizations seeking healthcare solutions.
CI Valuation & Market Position
With a $76.12B market cap, Cigna Corporation sits in the large-cap segment of the market. Relative to its peer group, CI's quantitative score of 79/100 is roughly in line with the peer average of 79/100.
FY2026 estForward Outlook
Wall Street analysts project Cigna Corporation revenue of about $284.92B for fiscal 2026, with EPS near $30.45. The estimate reflects 11 contributing analysts.
F-Score 7/9Financial Health
Cigna Corporation's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 2.81 places it in the grey zone, a middle ground that warrants monitoring.
ROE 15%Key Financial Metrics
Return on equity for Cigna Corporation stands at 15.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.1%, showing how much profit it generates from its asset base. CI trades at a trailing price-to-earnings ratio of 11.51, below the Healthcare sector average of ~23x. Its free cash flow yield is 10.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.82 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 8.7%, the inverse of the P/E and a quick read on earnings relative to price.
Net sellingInsider Activity
Over the past six months, Cigna Corporation insiders filed 30 SEC Form 4 transactions — 19 sales and 11 purchases. On net that is roughly 199K shares disposed (about $59.4M), a signal worth weighing alongside the fundamentals.
CI Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recientemente, la actividad de los insiders ha mostrado compras significativas, lo que sugiere confianza en el futuro de la empresa.
- La percepción de la comunidad ha sido positiva, con un aumento en las discusiones sobre el crecimiento potencial de Cigna en el sector de salud.
- Los desarrollos recientes en la expansión de sus servicios han generado entusiasmo entre los inversores, destacando su capacidad para adaptarse a las necesidades del mercado.
- Cigna ha mantenido una sólida reputación en la atención al cliente, lo que puede traducirse en lealtad y crecimiento sostenido.
Bear Case
- A pesar de la actividad positiva de los insiders, hay preocupaciones sobre la competencia creciente en el sector de seguros de salud.
- La comunidad ha expresado dudas sobre la capacidad de Cigna para gestionar costos en un entorno económico desafiante.
- Algunos analistas mencionan que la reciente volatilidad en el mercado podría afectar la confianza de los inversores en Cigna a corto plazo.
- Existen inquietudes sobre las regulaciones futuras que podrían impactar negativamente en las operaciones y márgenes de beneficio de la empresa.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
From the Earnings Call
“With our performance, we are raising our full year 2026 adjusted EPS outlook to at least $30.35, reflecting our disciplined approach and steady execution in an operating environment that continues to be shaped by many forces.”
— David Cordani, CEO
“Overall, Evernorth earnings were slightly ahead of expectations. This was driven by the strength of our Specialty and Care Services businesses, which delivered adjusted earnings growth of 20% in the quarter, reflecting continued attractive volume growth.”
— Brian Evanko, President and Chief Operating Officer
CI Q1 FY2026 earnings call transcript · 2026-04-30
CI Latest News
-
Cigna (CI) Stock Just Lost Its Place In Key Russell Growth Indexes
Yahoo! Finance: CI News · Jul 4, 2026
-
Cigna (CI) Stock Still Looks Cheap As Earnings Stay Strong
Yahoo! Finance: CI News · Jul 4, 2026
-
What Cigna Group (CI)'s US$100 Million Pharmacy Forward AI Bet Means For Shareholders
Yahoo! Finance: CI News · Jul 3, 2026
-
8 Health Care Stocks Whale Activity In Today’s Session
benzinga · Jul 3, 2026
CI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CI.
Price Targets
Consensus target: $332.62
CI MoonshotScore
What does this score mean?
The MoonshotScore rates CI's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
Cigna (CI) Stock Just Lost Its Place In Key Russell Growth Indexes
Cigna (CI) Stock Still Looks Cheap As Earnings Stay Strong
What Cigna Group (CI)'s US$100 Million Pharmacy Forward AI Bet Means For Shareholders
8 Health Care Stocks Whale Activity In Today’s Session
Leadership: David Michael Cordani
Chairman and Chief Executive Officer
David Cordani has served as Cigna's CEO since 2009. He holds a Bachelor of Arts degree from Lafayette College and an MBA from Temple University. Cordani has held various leadership positions within Cigna, including President and Chief Operating Officer. He is actively involved in healthcare policy and serves on the board of directors for several organizations, including the U.S. Chamber of Commerce.
Track Record: Under Cordani's leadership, Cigna has expanded its global presence and diversified its service offerings. He led the acquisition of Express Scripts in 2018, significantly enhancing Cigna's pharmacy benefit management capabilities. Cordani has also focused on driving innovation in healthcare technology and promoting value-based care models. Cigna's market capitalization has grown substantially during his tenure.
Common Questions About CI (Healthcare)
What does Cigna Corporation do?
Cigna Corporation is a global health service company that provides a wide range of insurance and related products and services. Through its Evernorth segment, Cigna offers pharmacy benefits management, care delivery, and health intelligence solutions. The Cigna Healthcare segment provides medical, dental, vision, and behavioral health plans. Cigna serves employers, individuals, and government organizations, focusing on delivering coordinated and cost-effective healthcare solutions.
What do analysts say about CI stock?
Analyst consensus on Cigna Corporation (CI) is generally positive, reflecting the company's strong market position and growth prospects. Key valuation metrics, such as the P/E ratio of 11.5, suggest that the stock may be undervalued. Growth considerations include the expansion of Evernorth services, growth in Medicare Advantage, and international market opportunities. Analysts also note the potential risks associated with regulatory changes and increasing competition in the healthcare industry.
What are the main risks for CI?
Cigna faces several key risks, including regulatory changes in the healthcare industry that could impact pricing and coverage. Increasing competition from other health insurers may pressure margins. Rising healthcare costs could affect profitability and affordability for customers. Cybersecurity threats and data breaches pose a risk to sensitive patient information. An economic downturn could reduce enrollment and premium revenue, impacting Cigna's financial performance.
How does Cigna's Evernorth segment contribute to the company's overall performance?
Cigna's Evernorth segment is a significant contributor to the company's performance, providing coordinated and point solution health services. Evernorth offers pharmacy benefits management, care delivery, and health intelligence solutions to health plans, employers, and government organizations. This integrated approach enhances Cigna's ability to manage healthcare costs, improve patient outcomes, and drive revenue growth. Evernorth's services are crucial for Cigna's competitive positioning and long-term success.
What are the key growth opportunities for CI in healthcare?
Cigna has several key growth opportunities in the healthcare sector. These include expanding its Medicare Advantage offerings to capture a larger share of the growing senior population, investing in digital health technologies to improve customer engagement and access to care, and expanding its presence in international markets to diversify its revenue streams. Additionally, Cigna can further integrate value-based care models to improve healthcare quality and reduce costs, enhancing its competitive position.
What are the key factors to evaluate for CI?
Cigna Corporation (CI) holds an AI score of 79/100 (high). P/E: 11.5x vs the S&P 500's ~20-25x. Analysts target $332.62 (+16%). Not financial advice.
How frequently does CI data refresh on this page?
CI prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CI's recent stock price performance?
Cigna Corporation (CI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified service offerings through Evernorth and Cigna Healthcare. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Financial metrics are as of the latest available reporting period.